ZAI LAB LTD0000006

Research ZAI LAB LTD0000006 (1ZLB) on Bullrun: market cap EUR 1.73B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• Ticker1ZLB
• ExchangeF
• CountryChina
• SectorHealthcare
• IndustryBiotechnology
• CurrencyEUR
• Market capEUR 1.73B
• Financial periodQ1 2026
• RevenueEUR 99.61M
• Net income-EUR 51.02M
• Free cash flow-EUR 34.20M
• Gross margin61.5%

Valuation Snapshot

latest market cap is EUR 1.73B.

About ZAI LAB LTD0000006

Zai Lab Limited, a biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases. Its commercial products include Zejula, an orally administered poly (ADP-ribose) polymerase 1/2 inhibitor for treating ovarian cancer; VYVGART, a human IgG1 antibody fragment for generalized myasthenia gravis and chronic inflammatory demyelinating polyneuropathy;

Frequently asked questions

What is ZAI LAB LTD0000006's market cap?

ZAI LAB LTD0000006's market capitalization is EUR 1.73B.

What does ZAI LAB LTD0000006 do?

Zai Lab Limited, a biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.